Manulife Financial stock reports stronger Q2 2026 results

Published on 10/06/2026 at 18:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Manulife Financial stock traded at CAD 61.41 on October 6, 2026, with a CAD 102.5 billion market value. Q2 APE sales rose 21 percent and core EPS grew 16 percent.

MFC, CA56501R1064, Illustration mit AI erstellt.

Manulife Financial stock was trading at CAD 61.41 on the Toronto Stock Exchange on October 6, 2026, up 0.20 percent from the prior session. The company enters the market's next checkpoint after Q2 2026 results showed double-digit growth in insurance sales and core earnings.

Q2 sales rose 21 percent

According to Benzinga in its Q2 2026 earnings transcript, annual premium equivalent sales increased 21 percent year over year, while core EPS grew 16 percent. New business CSM increased 16 percent, and the CSM balance grew 20 percent, adding a second quantified measure of future earnings capacity.

The profitability mix was uneven. Asia core earnings increased 21 percent year over year, Global WAM core earnings rose 9 percent, and Canada core earnings declined 10 percent because of unfavorable claims and expense experience in group insurance and individual insurance.

Capital strength meets risk transfer

Manulife reported core ROE of 16.3 percent in Q2 2026, 130 basis points higher than a year earlier, while its LICAT ratio reached 136 percent. The company also returned CAD 1.4 billion through dividends and share buybacks during the quarter, according to Benzinga.

The long-term care transaction is the main strategic counterpoint to the growth figures. Manulife transferred biometric risk on CAD 3.2 billion of reserves at an 80 percent quota share, and management said the transactions have reduced long-term care morbidity risk by 24 percent when combined with earlier deals. The deal is designed to lower risk while retaining the asset portfolio's earnings potential.

Consensus target remains above the quote

MarketBeat lists a Buy consensus based on eight analyst ratings and an average price target of USD 59.00. Its published comparison places that target 37.3 percent above the USD 42.98 reference price on the NYSE, a separate US listing from the Canadian reference quote used here.

Stock remains below yearly high

On the Toronto Stock Exchange, MFC's CAD 61.41 quote on October 6, 2026, stood below its CAD 63.58 52-week high and above its CAD 44.16 low. Market capitalization was CAD 102.5 billion, giving the Q2 operating figures a sizeable listed-company base.